Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
Launched by UNIVERSITY OF COLORADO, DENVER · Jan 25, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Nav-Team study is focusing on improving asthma management for children aged 4 to 12 who have persistent asthma, especially in families who speak languages other than English. The goal is to provide extra support and education through a program that connects families with asthma navigators, who are trained to help guide them in managing their child's asthma. The study will work with community organizations to understand what families need and will track how well the program is helping by looking at things like emergency room visits and overall satisfaction with the support provided.
To be eligible for this study, children must be between 4 and 12 years old and have asthma that requires regular medication. Their parent or guardian should be at least 18 years old and speak a language other than English at home. Participants can expect to receive personalized assistance in managing their child's asthma, which could include educational sessions and support from the asthma navigators. This program aims to make life easier for families dealing with asthma and to ensure they have the tools and knowledge needed to keep their children healthy.
Gender
ALL
Eligibility criteria
- eria for Nav-TEAM Intervention Dyads include:
- • Child aged 4-12 years.
- • Child with persistent asthma (defined by currently prescribed controller medication).
- • Parent/legal guardian who is at least 18 years old.
- Exclusion criteria for Nav-TEAM Intervention Dyads include:
- • Child aged under 4 and over 12 years of age.
- • Child with no persistent asthma (defined by currently prescribed controller medication).
- • Parent/legal guardian who is under 18 years old.
- • Any parent/legal guardian whose preferred spoken language is English.
- • Child requires additional continuous respiratory support (e.g,. tracheostomy with home ventilation, continuous daytime oxygen).
- • Child is enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
- • Spoken non-English preferred healthcare language of parent/legal guardian.
- • Child does NOT require additional continuous respiratory support (e.g., nighttime use of Continuous positive airway pressure machine for obstructive sleep apnea would be eligible).
- • Child does NOT have a complex medical/genetic condition that affects swallowing or lung function (e.g. g-tube with aspiration, cystic fibrosis)
- • Child is NOT enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported